Altamira Therapeutics Ltd. Gains 20.93%

Fri, Mar 10, 2023 at 07:07 PM
Altamira Therapeutics Ltd. Gains 20.93%

Altamira Therapeutics Ltd. (CYTO:NASDAQ) soared at $1.56, representing a gain of 20.9%. On Fri, Mar 10, 2023, CYTO:NASDAQ touched a New 2-Week Intraday Low of $1.2. The stock appeared on our News Catalysts scanner on Fri, Mar 03, 2023 at 09:52 AM in the 'BIOTECH' category. From Fri, Feb 24, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Mar 03, 2023 at $5.08 with a volume of 26M+.

About Altamira Therapeutics Ltd. (CYTO:NASDAQ)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.